Research & Development,Sales & Marketing,Public Health & Government,Payers & Providers,Medical Devices,Biosimilars.
Expert guidance and a wide range of testing programs to support medical device product development - from concept to commercialization.
Getting medical devices to market is a complex and difficult process in today's changing regulatory environment. AZR is uniquely positioned, with specialized programs and our many years of industry-leading experience, to provide the services and guidance manufacturers require.
AZR offers in-vivo and in-vitro non-clinical safety evaluation programs. As the uniqueness of each product requires a case-by-case approach, we partner with clients to ensure that all study components meet specific program objectives. Testing services are based on the current global regulatory guidelines and requirements, and our quality systems have been audited and accepted by regulatory authorities worldwide. AZR scientists have extensive experience in designing non-clinical safety testing programs, and our services have supported a number of successful regulatory submissions in the U.S., Europe and Asia. Testing Services
Acute Toxicity (in-vivo)
In-vitro Bacterial Mutagenicity
In-vitro Mouse Lymphoma
In-vitro Chromosomal Aberrations
In-vivo Mouse Micronucleus
Tissue Collection qPCR Analysis
Ubiquitous Biopharmaceuticals can achieve the same scale and efficiencies afforded by “big pharma,” all with the care and dedication of a personalized team.
As a Ubiquitous biopharma company, when you succeed the results are transformational. At the same time, you face a unique set of challenges--tighter budgets, access to varied industry expertise and continual demonstration of value to investors. You need to show results quickly and efficiently.
AZR understands these differences. Our Ubiquitous solutions are managed by dedicated teams to provide personalized service to you and your teams. In addition, you can tap into AZR scale across 45 countries and expertise.
Bring new therapies to market with more predictability, more efficiency. Find the advantage you need to win in the New Health.
For emerging biotechs to established global players – realize more from your investment.
Accelerate your product’s launch and reach the market gatekeepers who determine your product’s success.
To market your product, you now need to demonstrate greater value and improved patient outcomes while managing risk. AZR is uniquely positioned to help you achieve your ultimate goal: A drug that physicians prescribe, that patients adhere to and that payers endorse.
AZR has extensive experience and resources in emerging markets of Eastern Europe, India, South Africa, and Latin America which can offer many advantages over traditional clinical research markets including: